Skip to content

FIGS FIGS Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

1st Source Corporation logo
1st Source CorporationSRCE
$1.14B-8.9%
ProAssurance logo
ProAssurancePRA
$2.39B-3.9%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$461.4M-21.4%
Mosaic logo
MosaicMOS
$745.3M+5.0%
CTB
Community Trust BancorpCTBI
$943.49M+4.9%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$286.54M+23.4%

Other financials

Income statement

See full
Revenue$159.9M+28.0%
Gross profit$108.3M+28.2%
Operating income$4.5M+2,225%
Net income$6.3M+6,265%
EPS (diluted)$0.03

Balance sheet

See full
Cash & equivalents$74.3M-17.4%
Total debt$60.6M+18.1%
Total equity$430.6M+12.9%
Total assets$563.4M+7.9%

Cash flow

See full
Operating cash flow-$3.2M-135%
CapEx$2.4M+85.0%
Free cash flow-$5.6M-171%

Valuation

See full
Market cap$1.97B+229%

Profitability

See full
Gross margin66.6%-0.7pp
Operating margin6.4%+6.1pp
Net margin6.1%+5.9pp
FCF margin5.9%-4.9pp

Returns & leverage

See full
Return on equity10%+9.7pp
Debt / equity0.1×0.0×
Current ratio5.4×+1.4×

Where this comes from

Reported directly by FIGS in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: FIGS’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about FIGS's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FIGS's cash, cash equivalents, and marketable securities?
FIGS (FIGS) reported cash, cash equivalents, and marketable securities of $244.93M in Q1 2026.
How has FIGS's cash, cash equivalents, and marketable securities changed year-over-year?
FIGS's cash, cash equivalents, and marketable securities increased by 25.1% year-over-year, from $195.83M to $244.93M.
What is the long-term trend for FIGS's cash, cash equivalents, and marketable securities?
Over 3 years (2022 to 2025), FIGS's cash, cash equivalents, and marketable securities has grown at a 36.7% compound annual growth rate (CAGR), from $102.91M to $262.88M.
What does cash, cash equivalents, and marketable securities mean?
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.